Protein C, ein in der Leber gebildeter Gerinnungsinhibitor

• LITERATUR

• 1 Kisiel W. Human protein C. Isolation, characterization and mechanism of activation by α-thrombin. J. Clin. Invest. 64: 761 1979;
• 2 Mammen E.F, Thomas W.R, Seegers W.H. Activation of purified prothrombin to autoprothrombin I or autoprothrombin II (platelet cofactor II) or autoprothrombin IIa. Thromb. Diathes. Haemorrh. 5: 218 1960;
• 3 Seegers W.H, Nova A.E, Henry R, Hassoena H. Relationship of »new« vitamin K dependent protein C and »old« autoprothrombin II-A. Thromb. Res. 8: 543 1976;
• 4 Esmon C.T, Owen W.G. Identification of an endothelial cell cofactor for thrombin-catalized activation of protein C. Proc. Natl. Acad. Sci. USA 78: 2245 1981;
• 5 Esmon C.T, Naomi L.E, Harris W.K. Complex formation between thrombin and thrombomodulin inhibits both thrombin catalyzed fibrin formation and factor V activation. J. Biolog. Chem. 257: 7944 1982;
• 6 Suzuki K, Stenflo J, Dahlbäck B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J. Biolog. Chem. 258: 1914 1983;
• 7 Kisiel W, Canfield W.M, Ericsson L.H, Davie E.W. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 16: 5824 1977;
• 8 Canfield W, Nesheim M, Kisiel W, Mann K.G. Proteolytic inactivation of bovine factor Va by bovine activated protein C. Circulation 57/58, Suppl ii: 210 1978;
• 9 Dahlbäck B, Stenflo J. Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa. Eur. J. Biochem. 107: 331 1980;
• 10 Comp P.C, Esman C.T. Activated protein C inhibitis platelet prothrombin-converting activity. Blood 54: 1272 1979;
• 11 Comp P.C, Esmon C.T. Generation of in vivo fibrinolytic activity by infusion of activated protein C into dogs. Circulation 62, Suppl III: 334 1980;
• 12 Comp P.C, Esmon C.T. Initiation of clot lysis in plasma by activated protein C. Circulation 57/58, Suppl ii: 210 1978;
• 13 Griffin J.H, Evatt B, Zimmerman T.S, Kleiss A.J. Deficiency of protein C in congenital thrombotic disease. J. Clin. Invest. 68: 1370 1981;
• 14 Bertina R.M, Broekmans A.W, van der Linden I.K, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb. Hemost. 48: 1 1982;
• 15 Bertina R.M, Broeckmans A.W, van Es-Krommenboeck T, Wijngaarden A. The use of a functional assay for plasma protein C in the diagnosis of protein C deficiency. Thromb. Hemost. 50: 350 (Abstract 1097) 1983;
• 16 Sala N, Owen W.G, Collen D. A functional assay of protein C in human plasma. Blood (in print).
• 17 Francis R.B, Patch M.J. A functional assay of protein C in human plasma. Thromb. Res. 32: 605 1983;
• 18 Marlar R.A, Endres-Brooks J. Recurrent thromboembolic disease due to heterozygous protein C deficiency. Thromb. He-most. 50: 351 (Abstract 1102) 1983;
• 19 Pabinger-Fasching L, Bertina R.M, Lechner K, Niessner H, Korninger C. Protein C deficiency in two Austrian families. Thromb. Hemost. 50: 810 1983;
• 20 Griffin J.H, Mosher D.F, Zimmerman T.S, Kleiss A.J. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 60: 261 1982;
• 21 Manucci P.M, Vigano S. Deficiencies of protein C, an inhibitor of blood coagulation. Lancet II: 463 1982;
• 22 Broeckmans A.W, Veltkamp J.J, Bertina R.M. Congenital protein C deficiency and venous thromboembolism. New Engl. J. Med. 306: 340 1983;
• 23 Broeckmans A.W, Bertina R.M, Loeliger E.A, Hofmann V, Klingemann H.-G. Protein C and the development of skin necrosis during anticoagulant therapy. Thromb. Haemost. 49: 251 1983;
• 24 Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clinics in Haemat. 10: 369 1981;
• 25 Vigano S, Manucci P.M, Solinas S, Bottasso B, D’Angelo A, Mariani G. Early fall of protein C during short term anticoagulant treatment. Thromb. Hemost. 50: 310 (Abstract 0986) 1983;
• 26 Thaler E, Balzar E, Kopsa H, Pinggera W.F. Aquired antithrombin III deficiency in patients with glomerular proteinuria. Haemostasis 7: 257 1978;